Stock screener

AKTS

Conviction 72HealthcareScan · Mon, Aug 10, 2026
AKTS$24.16+0.10%
ResistanceSupportVol 14Insider sell
63 bars
6
Vol MA14 283.48K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Aktis Oncology, Inc.Biotechnologywww.aktisoncology.com ↗
Price24.16
Change+0.10%
Gap-0.46%
Rel volume1.52×
Avg volume311.99K
Avg $ vol7.47M
SMA 2023.82
SMA 5024.29
SMA 20015.34
Price vs 50-0.57%
Price vs 200+57.44%
MA stackmixed
50/200 cross—
Supertrenddown · 26.94
RSI (14)50
MACD hist0.02
MACD crossbull · 0d
Stoch %K / %D73 / 66
ADX (14)22
+DI / −DI20 / 20
RSI divergence—
MACD divergenceBullish
ATR %+6.73%
ADR %5.75%
52w high32.23
52w low0.0372
From 52w high-25.05%
Above 52w low+64832.80%
New 52w highNo
SqueezeOn · 2d
Bollinger width17.90%
%B0.58
Donchian pos50.81%
Donchian high26.88
Donchian low21.34
AVWAP (52w high)26.63
vs AVWAP high-9.30%
AVWAP (52w low)6.83
vs AVWAP low+253.67%
OBV trendFlat
Chaikin MF (20)-0.22
Today vs 20d1.52×
Avg vol (14d)283.48K
Avg vol (20d)311.99K
Avg $ vol (20d)7.47M
Market cap1.29B
RS 3m (vs SPY)+22.38%
RS 6m (vs SPY)+9.19%
RS line new highNo
Trend template6/8
Technical rank68.7
1 week+8.66%
1 month-13.36%
3 months+29.87%
6 months+27.27%
1 year+19177.73%
YTD+7.83%
P/E—
P/B2.55
P/S—
P/FCF—
EPS—
Div yield—
ROE—
ROA—
Debt/Eq—
Current19.49
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth—
Price target35.50
Target upside46.97%
Analyst ratingBuy
Institutional65.77%
Ent. value918.32M
Revenue3.23M
Net income-18.32M
Gross profit—
Free cash flow—
IndustryBiotechnology
ExchangeNasdaq
Shares out53.4M
Employees79
ListedFri, Jan 9, 2026
Free float23M
Float %43.1%
Short interest3.74M
Days to cover6.3d
Short volume78.7%
Squeeze score85 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.38 vs −$0.31
Last surprise-22.6% miss
Setup gradeB
Conviction72 / 100
Pattern quality—
Tech rank68.7 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance33.86
Support21.79
Days since event—
Candle confirm—
News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Signal lifecycle

How this symbol has moved through the lanes across 46 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

  1. Setting up
    Jun 12
    1 scan
  2. Breaking out now
    Jun 15 – Jun 16
    2 scans
  3. Broke out
    Jun 18 – Jun 22
    2 scans

Congress activity

Disclosed STOCK Act trades in AKTS

All disclosures →
No recent disclosed trades by Congress in AKTS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in AKTS · 2 buys · 8 sells

InsiderSideShares
Czibere Akos
Chief Medical Officer · Common Stock · 2026-07-08
Exercise50K
Czibere Akos
Chief Medical Officer · Common Stock · 2026-07-08
Sell14.8K
Czibere Akos
Chief Medical Officer · Common Stock · 2026-07-08
Sell30.83K
Czibere Akos
Chief Medical Officer · Common Stock · 2026-07-08
Sell4.37K
Czibere Akos
Chief Medical Officer · Stock Option (Right to Buy) · 2026-07-08
Exercise50K
Ron-Bigger Shulamit
Chief Operating Officer · Common Stock · 2026-07-08
Exercise50K
Ron-Bigger Shulamit
Chief Operating Officer · Common Stock · 2026-07-08
Sell15.8K
Ron-Bigger Shulamit
Chief Operating Officer · Common Stock · 2026-07-08
Sell30K
Ron-Bigger Shulamit
Chief Operating Officer · Common Stock · 2026-07-08
Sell4.2K
Ron-Bigger Shulamit
Chief Operating Officer · Stock Option (Right to Buy) · 2026-07-08
Exercise50K

SEC filings

EDGAR filings in AKTS · 4 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.